ABEONA THERAPEUTICS INC. — Director's Dealing 2021

Oct 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-10-15

Reporting Person: Seshadri Vishwas (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-15	Common stock	A	50000	—	Acquired	350000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-15	Stock Option (right to buy)	$0.91	A	300000	Acquired	2031-10-15	Common Stock (300000)	Direct

Footnotes

F1: The restricted stock will vest 25% on each of October 15, 2022, October 15, 2023, October 15, 2024 and October 15, 2025.

F2: The options will vest 25% on October 15, 2022, and in 36 equal monthly installments thereafter.